Clinical Trial Update: Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating an unrelated cord blood transplant plus a haplo-identical, T-cell depleted stem cell transplant from a related donor for hig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Hematologic Malignancies
• Myelodysplastic Syndrome

Snippet

Sponsor: Joanne Kurtzberg, MD | Conditions: Hematologic Malignancy, Myelodysplastic Syndrome (MDS) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-12-24